Table 5 Expected Value of Perfect Information (1000 Patients, 30 years)
From: Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis
Intervention* | Willingness to pay ($/QALY) | Population EVPI ($) |
|---|---|---|
Low Risk | Â | Â |
Null Scenario | - | - |
Thiazide diuretic | 2,700 | 2,066,053 |
ACEI | 15,000 | 18,246,980 |
Medium Risk | Â | Â |
Null Scenario | - | - |
Thiazide diuretic | 1,300 | 1,235,304 |
CCB | 15,000 | 38,307,837 |
High Risk | Â | Â |
Null Scenario | - | - |
Thiazide | 1,400 | 894,629 |
CCB | 12,500 | 22,299,390 |